title: [Chronic myeloid leukemia treatment and human immunodeficiency virus infection].
authors.affiliation: Servicio de Medicina Interna, Hospital Severo Ochoa, Leganés, Madrid, España. Electronic address: davidcr85@hotmail.com.
authors.forename: D
authors.initials: D
authors.lastname: Campillo-Recio
authors.affiliation: Servicio de Medicina Interna, Hospital Severo Ochoa, Leganés, Madrid, España.
authors.forename: L
authors.initials: L
authors.lastname: Perez-Rodriguez
authors.affiliation: Servicio de Medicina Interna, Hospital Severo Ochoa, Leganés, Madrid, España.
authors.forename: E
authors.initials: E
authors.lastname: Yebra
authors.affiliation: Servicio de Medicina Interna, Hospital Severo Ochoa, Leganés, Madrid, España.
authors.forename: M
authors.initials: M
authors.lastname: Cervero-Jimenez
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001549:Benzamides / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy; D008297:Male; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents; D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate